• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
SUI Jiying,GAO Cong,DOU Mingjin.Research progress on novel drug delivery systems of Irinotecan[J].Journal Of Pharmaceutical Research,2019,38(8):490-493[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 3191times   Download 2911次 QR Code for this article
Scan with your phone!
伊立替康新型载药系统的研究机制
隋继英,高丛,窦明金
Font:Larger+|Default|Smaller-
(山东省医学科学院附属医院,山东 济南 250031)
摘要:
伊立替康是喜树碱衍生物,属于拓扑异构酶I抑制剂,具有广谱的抗肿瘤作用。在临床应用中,无论单药使用还是联合其它药物治疗癌症,都取得了较好的效果。由于药物的半衰期短以及严重的毒副作用,限制了伊立替康在临床上的应用。伊立替康新型载药系统具有缓释作用,可进一步提高药物的生物利用度,同时降低毒副作用,因此成为近年来国内外学者的研究热点。本文主要介绍伊立替康在纳米粒、脂质体和微球等新型载药系统的研究进展。
关键词:  伊立替康  纳米粒  脂质体  微球  载药系统
DOI:10.13506/j.cnki.jpr.2019.08.013
基金项目:
Research progress on novel drug delivery systems of Irinotecan
SUI Jiying,GAO Cong,DOU Mingjin
(Affiliated Hospital of Shandong Academy of Medical Science,Jinan 250031,China)
Abstract:
Irinotecan is a camptothecin derivative belonging to the topoisomerase I inhibitors,which has broad-spectrum antitumor activities.In clinical applications both single drug treatment and multiple chemotherapy of irinotecan have achieved good therapeutic effects.However, disadvantages of irinotecan,such as short half-life and poor biocompatibility have limited its widely clinical use.Novel drug delivery systems which with high bioavailability and low side effects have become the focus in recent years.The article summarized the research progress of irinotecan on the new drug carriers,such as nanoparticles,liposomes and microspheres.
Key words:  Irinotecan  Nanoparticles  Liposomes  Microspheres  Drug delivery system
Today's Visits:468    Total Visits:2383167
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.